JPH11302257A5 - - Google Patents

Info

Publication number
JPH11302257A5
JPH11302257A5 JP1998297011A JP29701198A JPH11302257A5 JP H11302257 A5 JPH11302257 A5 JP H11302257A5 JP 1998297011 A JP1998297011 A JP 1998297011A JP 29701198 A JP29701198 A JP 29701198A JP H11302257 A5 JPH11302257 A5 JP H11302257A5
Authority
JP
Japan
Prior art keywords
formula
chlorine
hydrogen
alkoxy
benzyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998297011A
Other languages
English (en)
Japanese (ja)
Other versions
JP3782591B2 (ja
JPH11302257A (ja
Filing date
Publication date
Priority claimed from DE19746287A external-priority patent/DE19746287A1/de
Application filed filed Critical
Publication of JPH11302257A publication Critical patent/JPH11302257A/ja
Publication of JPH11302257A5 publication Critical patent/JPH11302257A5/ja
Application granted granted Critical
Publication of JP3782591B2 publication Critical patent/JP3782591B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP29701198A 1997-10-20 1998-10-19 置換イソキノリン−3−カルボキサミド、その製法および薬剤としてのその使用 Expired - Lifetime JP3782591B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746287A DE19746287A1 (de) 1997-10-20 1997-10-20 Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19746287:1 1997-10-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005254578A Division JP4691419B2 (ja) 1997-10-20 2005-09-02 置換イソキノリン−3−カルボキサミド、その製法および薬剤としてのその使用

Publications (3)

Publication Number Publication Date
JPH11302257A JPH11302257A (ja) 1999-11-02
JPH11302257A5 true JPH11302257A5 (cg-RX-API-DMAC7.html) 2005-10-27
JP3782591B2 JP3782591B2 (ja) 2006-06-07

Family

ID=7846053

Family Applications (2)

Application Number Title Priority Date Filing Date
JP29701198A Expired - Lifetime JP3782591B2 (ja) 1997-10-20 1998-10-19 置換イソキノリン−3−カルボキサミド、その製法および薬剤としてのその使用
JP2005254578A Expired - Lifetime JP4691419B2 (ja) 1997-10-20 2005-09-02 置換イソキノリン−3−カルボキサミド、その製法および薬剤としてのその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005254578A Expired - Lifetime JP4691419B2 (ja) 1997-10-20 2005-09-02 置換イソキノリン−3−カルボキサミド、その製法および薬剤としてのその使用

Country Status (24)

Country Link
US (1) US6093730A (cg-RX-API-DMAC7.html)
EP (2) EP1538160B1 (cg-RX-API-DMAC7.html)
JP (2) JP3782591B2 (cg-RX-API-DMAC7.html)
KR (1) KR100618922B1 (cg-RX-API-DMAC7.html)
CN (1) CN1117079C (cg-RX-API-DMAC7.html)
AR (1) AR013696A1 (cg-RX-API-DMAC7.html)
AT (2) ATE432940T1 (cg-RX-API-DMAC7.html)
AU (1) AU755714B2 (cg-RX-API-DMAC7.html)
BR (1) BR9804504B1 (cg-RX-API-DMAC7.html)
CA (2) CA2250664A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ337298A3 (cg-RX-API-DMAC7.html)
DE (3) DE19746287A1 (cg-RX-API-DMAC7.html)
DK (2) DK0911340T3 (cg-RX-API-DMAC7.html)
ES (2) ES2245471T3 (cg-RX-API-DMAC7.html)
HU (1) HUP9802422A3 (cg-RX-API-DMAC7.html)
ID (1) ID21115A (cg-RX-API-DMAC7.html)
IL (1) IL126638A0 (cg-RX-API-DMAC7.html)
NO (1) NO312365B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ332363A (cg-RX-API-DMAC7.html)
PL (1) PL192354B1 (cg-RX-API-DMAC7.html)
PT (1) PT911340E (cg-RX-API-DMAC7.html)
SG (1) SG87776A1 (cg-RX-API-DMAC7.html)
TR (1) TR199802106A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA989505B (cg-RX-API-DMAC7.html)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001275014A1 (en) * 2000-05-30 2001-12-11 Neurogen Corporation Imidazoloisoquinolines
US6762318B2 (en) * 2001-12-03 2004-07-13 Novo Nordisk A/S Glucagon antagonists
US8318703B2 (en) 2001-12-06 2012-11-27 Fibrogen, Inc. Methods for improving kidney function
HU229475B1 (en) 2001-12-06 2014-01-28 Fibrogen Methods of increasing endogenous erythropoietin (epo)
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
US7618940B2 (en) 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
US8124582B2 (en) 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
WO2005007192A2 (en) * 2003-06-06 2005-01-27 Fibrogen, Inc. Cytoprotection through the use of hif hydroxylase inhibitors
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
CN103145616B (zh) * 2003-06-06 2015-09-30 菲布罗根有限公司 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途
CN101849943A (zh) * 2005-06-06 2010-10-06 菲布罗根公司 使用HIFα稳定剂的改进的贫血治疗
AU2006259352A1 (en) 2005-06-15 2006-12-28 Fibrogen, Inc. Use of HIF 1alfa modulators for treatment of cancer
AU2006326662B2 (en) 2005-12-09 2011-07-28 Amgen Inc. Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
CN102351791B (zh) 2006-01-27 2014-10-29 菲布罗根有限公司 使低氧诱导因子(hif)稳定的氰基异喹啉化合物
US7625927B2 (en) 2006-02-27 2009-12-01 Alcon Research, Ltd. Method of treating glaucoma
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
KR100934671B1 (ko) * 2006-03-30 2009-12-31 엘지전자 주식회사 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치
AU2007234408B2 (en) 2006-04-04 2011-05-19 Fibrogen, Inc. Pyrrolo- and thiazolo-pyridine compounds as HIF modulators
NZ623002A (en) 2006-06-26 2015-08-28 Akebia Therapeutics Inc Prolyl hydroxylase inhibitors and methods of use
WO2008076427A2 (en) 2006-12-18 2008-06-26 Amgen Inc. Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
US8048892B2 (en) 2006-12-18 2011-11-01 Amgen Inc. Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
EP2142509B1 (en) 2007-04-18 2013-12-04 Amgen, Inc Quinolones and azaquinolones that inhibit prolyl hydroxylase
ES2446418T3 (es) 2007-04-18 2014-03-07 Amgen, Inc Derivados de indanona que inhiben la prolil hidroxilasa
US8030346B2 (en) 2007-05-04 2011-10-04 Amgen Inc. Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity
CA2685219C (en) 2007-05-04 2012-06-19 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
US8962530B2 (en) * 2007-06-27 2015-02-24 Regents Of The University Of Colorado Inflammatory bowel disease therapies
CN101497584B (zh) * 2008-01-29 2010-12-22 首都医科大学 异喹啉-3-甲酰氨基酸苄酯及其制备和应用
PT2294066E (pt) 2008-04-28 2014-11-21 Janssen Pharmaceutica Nv Benzoimidazoles como inibidores da prolil-hidroxilase
WO2010056767A1 (en) 2008-11-14 2010-05-20 Fibrogen, Inc. Thiochromene derivatives as hip hydroxylase inhibitors
US8283465B2 (en) * 2009-07-17 2012-10-09 Japan Tobacco Inc. Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
NO2686520T3 (cg-RX-API-DMAC7.html) 2011-06-06 2018-03-17
CA2842730C (en) * 2011-07-22 2018-08-21 Beijing Betta Pharmaceuticals Co., Ltd Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
ES2818977T3 (es) 2011-10-25 2021-04-14 Janssen Pharmaceutica Nv Método para obtener cristales de sal de meglumina de ácido 1-(5,6-dicloro-1H-benzo[d]imidazol-2-il)-1H-pirazol-4-carboxílico
WO2013134660A1 (en) 2012-03-09 2013-09-12 Fibrogen, Inc. 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors
EP3470397B1 (en) 2012-07-16 2021-12-29 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
SG11201500234YA (en) 2012-07-16 2015-02-27 Fibrogen Inc Process for making isoquinoline compounds
US9822135B2 (en) 2012-10-30 2017-11-21 H. Lee Moffitt Cancer Center And Research Institute, Inc. STAT3 dimerization inhibitors
SG10202009266PA (en) 2013-01-24 2020-10-29 Fibrogen Inc Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
IL296484B2 (en) 2013-06-06 2025-03-01 Fibrogen Inc Pharmaceutical formulations of HIF hydroxylase inhibitor
HUE066123T2 (hu) 2013-06-13 2024-07-28 Akebia Therapeutics Inc Készítmények és módszerek anémia kezelésére
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
MX384843B (es) 2014-05-15 2025-03-14 Insmed Inc Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas.
CA2974691A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
NZ735973A (en) 2015-04-01 2023-06-30 Akebia Therapeutics Inc Compositions and methods for treating anemia
EP4667059A3 (en) * 2015-05-28 2026-04-08 Japan Tobacco Inc. Method for treating or preventing diabetic nephropathy
ES2898340T3 (es) * 2015-07-09 2022-03-07 Insmed Inc Composiciones y métodos para tratar neumopatías y lesión pulmonar
AR108326A1 (es) 2016-04-27 2018-08-08 Samumed Llc Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
AR108325A1 (es) 2016-04-27 2018-08-08 Samumed Llc Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
KR20200112872A (ko) * 2018-01-09 2020-10-05 코넬 유니버시티 장기 섬유증의 예방 및 치료
EP3773505B1 (en) 2018-03-30 2026-04-29 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
EP3787602A4 (en) 2018-05-02 2022-03-23 Insmed Incorporated PROCESS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS
US11713298B2 (en) 2018-05-09 2023-08-01 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
EP3829623A4 (en) * 2018-08-03 2022-10-19 Cornell University METHODS OF REDUCING ABNORMAL SCAR FORMATION
TWI865563B (zh) 2019-07-30 2024-12-11 德商拜耳動物保健有限公司 新穎異喹啉衍生物
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
US12612367B2 (en) 2019-12-10 2026-04-28 Akebia Therapeutics, Inc. Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative
CN112979541B (zh) * 2019-12-17 2022-11-11 浙江大学 一种基于n-(3-羟基吡啶-2-羰基)甘氨酸的抗肿瘤药物增敏剂及其应用
WO2021216530A1 (en) 2020-04-20 2021-10-28 Akebia Therapeutics, Inc. Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer
CN116120340B (zh) * 2021-11-15 2023-10-31 艾立康药业股份有限公司 一种吡啶并噁嗪类化合物及其制备方法、组合物和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4015255A1 (de) * 1990-05-12 1991-11-14 Hoechst Ag Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase
CA2085954A1 (en) * 1991-12-24 1993-06-25 Klaus Weidmann Substituted pyridine n-oxides, processes for their preparation, and their use
TW352384B (en) * 1992-03-24 1999-02-11 Hoechst Ag Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
DE4233124A1 (de) * 1992-10-02 1994-04-07 Hoechst Ag Acylsulfonamido- und Sulfonamidopyridin-2-carbonsäureester sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE149485T1 (de) * 1993-11-02 1997-03-15 Hoechst Ag Substituierte heterocyclische carbonsäureamidester, ihre herstellung und ihre verwendung als arzneimittel
EP0650961B1 (de) * 1993-11-02 1997-03-05 Hoechst Aktiengesellschaft Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
CA2138929A1 (en) * 1993-12-30 1995-07-01 Klaus Weidmann Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid

Similar Documents

Publication Publication Date Title
JP2895145B2 (ja) 鎮痛剤として用いられるn―フエニル―n―(4―ピペリジニル)アミド
US6528661B2 (en) Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
KR100284838B1 (ko) 새로운 아릴프로피온 유도체, 그 제조방법 및 진통제로서의 이용방법
JP2005526011A5 (cg-RX-API-DMAC7.html)
JPH07215937A (ja) 3,3,4−トリ置換ピペリジニル−n−アルキルカルボン酸塩および中間体
CA2251647A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
JP4048119B2 (ja) 2−(4−クロロベンゾイルアミノ)−3−[2(1h)−キノールリノン−4−イル]プロピオン酸の製造方法
PT2044021E (pt) Processo para preparar o remifentanilo, seus intermediários, utilização dos referidos intermediários e processos para a sua preparação
JP2002513761A (ja) sPLA2阻害剤エステル
JP3187905B2 (ja) ラセミおよび光学活性1,2,3,4−テトラヒドロイソキノリン−3−カルボン酸およびその前駆体の製造方法
JP2572774B2 (ja) カルボン酸の合成方法
FI77445B (fi) Foerfarande foer framstaellning av ett indolderivat.
JPH06179649A (ja) アミノ酸誘導体および該誘導体を有効成分として含有するエンケファリナーゼ阻害剤
EP0031653A1 (en) N-Substituted alpha-amino acids, processes for making them and pharmaceutical compositions containing them
EP1628956B1 (en) A process for the preparation of compounds having an ace inhibitory action
JP2730135B2 (ja) 酸アミド誘導体
JP2001522825A5 (cg-RX-API-DMAC7.html)
CN1252035C (zh) 新型手性氨基酸衍生物及其合成方法与应用
JP2002540101A (ja) プロピオン酸3−アミノ−3−アリールの合成
JP2005532362A (ja) インドール誘導スタチンのカルシウム塩
JP3179895B2 (ja) 新規なコハク酸誘導体
JPH0995477A (ja) グアニジン誘導体及びその製造方法
CN1030408A (zh) 环氨基酸衍生物、它们的盐、含有它的药物组成及其制备方法
Voynikov et al. Novel leucine derived amides of theophylline-7-acetic acid
JPH083162A (ja) イミダゾピリジン誘導体及びその製法